GSK's HIV-prevention drug Apretude approved by European Commission By Proactive Investors
|
Known
scientifically as cabotegravir, Apretude can be used in combination with
safe-sex practices to reduce the risk of sexually acquired HIV-1 ... |
Impact of US funding cuts on HIV programmes in Angola
While stocks of antiretroviral supplies, HIV, viral load and other lab test kits are available, recent reports indicate challenges with distribution. View article...